Stefan Braam | Cellistic

Two decades ago, the discovery of induced pluripotent stem cells (iPSCs) promised to revolutionize medicine. Today, we are finally seeing that promise translate into life-changing clinical realities.

In this episode of Partner.bio at BIO 2026, we visit the Belgium Pavilion to catch up with Stefan Braam, an industry veteran who has spent the last 20 years pioneering the iPSC space, now leading advancements with Cellestic.

Stefan dives into why this year marks a massive turning point for cell therapies, moving the needle from academic potential to undeniable patient impact.